Clinical Trials
20 trialsNCT00700778 2021-01-25
Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
Fox Chase Cancer Center
Phase NA Terminated
NCT00899548 2019-07-26
DNA in Predicting Response After Systemic Therapy in Women With Metastatic Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
NCT00904514 2018-10-05
Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial
National Institutes of Health Clinical Center (CC)
Terminated
NCT00088829 2018-07-11
Genetic Testing in Predicting Response to Paclitaxel in Women With Breast Cancer
Georgetown University
Phase 2 Terminated
NCT00898937 2018-04-13
Gene Expression in Tumor Tissue From Women Undergoing Surgery for Breast Cancer or Core Biopsy of the Breast
Georgetown University
Terminated
NCT01105312 2017-06-27
Panobinostat and Letrozole in Treating Patients With Metastatic Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 1/2 Completed
NCT00897299 2017-05-17
Identifying Genes That Predict Recurrence in Women With Breast Cancer Treated With Chemotherapy
Eastern Cooperative Oncology Group
Completed
NCT00897845 2017-05-17
Studying Tumor Samples From Women Who Have Undergone Chemotherapy for Breast Cancer
Eastern Cooperative Oncology Group
Completed
NCT00379509 2017-03-21
Lapatinib and Radiation Therapy in Treating Patients With Locally Recurrent or Chemotherapy-Refractory Locally Advanced or Metastatic Breast Cancer
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT01004796 2016-02-29
Study of Biomarkers in Tissue Samples From Patients With Breast Cancer
National Cancer Institute (NCI)
Unknown
NCT01420185 2015-05-08
Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28
NSABP Foundation Inc
Unknown
NCT00463034 2013-12-18
Genes That Affect Disease Progression in Women With Newly Diagnosed or Metastatic Breast Cancer
National Cancer Institute (NCI)
Unknown
NCT00898690 2013-12-18
Gene Expression in Predicting Response to Paclitaxel in Patients With Breast Cancer
National Cancer Institute (NCI)
Unknown
NCT00017095 2013-10-24
Biomarker (p53 Gene) Analysis and Combination Chemotherapy Followed by Radiation Therapy and Surgery in Treating Women With Large Operable or Locally Advanced or Inflammatory Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3 Completed
NCT00070278 2013-08-07
Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00897065 2013-07-10
Biomarkers in Predicting Response to Tamoxifen and Letrozole in Postmenopausal Women With Primary Breast Cancer Treated on Clinical Trial CAN-NCIC-MA17
National Cancer Institute (NCI)
Unknown
NCT00897091 2013-05-30
S8814A Biomarkers in Predicting Outcome in Postmenopausal Women With Hormone Receptor-Positive, Node-Positive Breast Cancer Treated With Tamoxifen With or Without Cyclophosphamide, Doxorubicin, and Fluorouracil
SWOG Cancer Research Network
Completed
NCT00914043 2013-01-11
Studying Biological Markers of Fatigue in Women With Residual Invasive Breast Cancer Enrolled on Clinical Trial NSABP-B-45
NSABP Foundation Inc
Withdrawn
NCT00900406 2012-11-06
Collecting and Storing Tissue and DNA Samples From Patients Undergoing a Donor Stem Cell Transplant
Vanderbilt-Ingram Cancer Center
Completed
NCT00080860 2012-03-08
Sentinel Lymph Node Biopsy and Primary Tumor Gene Expression Profiling in Finding Axillary Lymph Node Metastases in Women Who Have Received Neoadjuvant Therapy for Stage II, Stage III, or Stage IV Breast Cancer
National Institutes of Health Clinical Center (CC)
Phase NA Completed